Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin

Diseases of the Colon and Rectum

Volumn 54, Issue 3, 2011, Pages 293-299

  Youssef, Haney ^a   Newman, Christopher ^a   Chandrakumaran, Kandiah ^a   Mohamed, Faheez ^a   Cecil, Tom D ^a   Moran, Brendan J ^a  

^a BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

Appendix tumor; Complete cytoreduction; Debulking surgery; Mucinous appendiceal neoplasm; Pseudomyxoma peritonei

Indexed keywords

FLUOROURACIL; LOW MOLECULAR WEIGHT HEPARIN; MITOMYCIN C;

ABDOMINAL SURGERY; ADULT; AGED; ANASTOMOSIS LEAKAGE; APPENDIX TUMOR; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLON RESECTION; COMPRESSION GARMENT; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HALLUCINATION; HEMICOLECTOMY; HUMAN; HYPERTHERMIC THERAPY; ILEOSTOMY; INTESTINE FISTULA; LAPAROTOMY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; NEUTROPENIA; OMENTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS DISEASE; PERITONECTOMY; PERITONEUM PSEUDOMYXOMA; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; REOPERATION; SURGICAL INFECTION; SURGICAL MORTALITY; SURVIVAL TIME; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM; VISCERAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; APPENDICEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952748515     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e318202f026     Document Type: Article

References (31)

1. National Institute for Health and Clinical Excellence (NICE). Complete cytoreduction for pseudomyxoma peritonei (SugarbakerTechnique) 2004. http://www.nice.org.uk/Guidance/IPG56. Accessed April 1, 2010.
2. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34:196-201.
3. Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12:585-603. (Pubitemid 36920087)
4. Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg. 2000;87:1414-1418.
5. Gough DB, Donohue JH, Schutt AJ, et al. Pseudomyxoma peritonei: long-term patient survival with an aggressive regional approach. Ann Surg. 1994;219:112-119. (Pubitemid 24064067)
6. Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241: 300-308.
7. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727-731. (Pubitemid 30013648)
8. Witkamp AJ, de Bree E, Kaag MM, et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer. 2001;37: 979-984. (Pubitemid 32397682)
9. Elias D, Laurent S, Antoun S, et al. Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy [in French]. Gastroenterol Clin Biol. 2003;27: 407-412. (Pubitemid 36987541)
10. Deraco M, Baratti D, Inglese MG, et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol. 2004;11:393-398. (Pubitemid 40486749)
11. Güner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis. 2005;20:155-160. (Pubitemid 40227522)
12. Loungnarath R, Causeret S, Bossard N, et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum. 2005;48:1372-1379. (Pubitemid 40933864)
13. Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms. Br J Surg. 2006;93:1270-1276. (Pubitemid 44547028)
14. Stewart JH IV, Shen P, Russell GB, et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol. 2006;13:624-634.
15. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome. Ann Surg Oncol. 2007;14: 493-499. (Pubitemid 46175293)
16. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104-109. (Pubitemid 46035441)
17. Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008; 15:526-534.
18. Moran BJ, Mukherjee A, Sexton R. Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg. 2006;93:100-104. (Pubitemid 43117313)
19. Murphy EM, Sexton R, Moran BJ. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum. 2007;50:37-42. (Pubitemid 46147019)
20. Elias D, Honoré C, Ciuchendéa R, et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2008;95: 1164-1171.
21. van Leeuwen BL, Graf W, Pahlman L, Mahteme H. Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol. 2008;15:745-753.
22. Rout S, Renehan AG, Parkinson MF, et al. Treatments and outcomes of peritoneal surface tumors through a centralized national service (United Kingdom). Dis Colon Rectum. 2009;52: 1704-1714.
23. Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008;98:277-282.
24. Garofalo A, Valle M, Garcia J, Sugarbaker PH. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol. 2006;32:682-685. (Pubitemid 44064001)
25. Ba MC, Cui SZ, Lin SQ, et al. Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites. World J Gastroenterol. 2010;16: 1901-1907.
26. Common Terminology Criteria for Adverse Events (CTCAE) v3.0 Online Instructions and Guidelines. https://webapps.ctep.nci.nih.gov/webobjs/ctc/ webhelp/welcome-to-ctcae.htm. Accessed August 16, 2010.
27. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104-109. (Pubitemid 46035441)
28. Moran BJ. Decision-making and technical factors account for the learning curve in complex surgery. J Public Health. 2006;28: 375-378. (Pubitemid 44863329)
29. Smeenk RM, Verwaal VJ, Zoetmulder FA. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg. 2007;94:1408-1414. (Pubitemid 350144391)
30. Chua TC, Yan TD, Smigielski ME, et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol. 2009;16:1903-1911.
31. Khan AA, Wheeler JM, Cunningham C, George B, Kettlewell M, Mortensen NJ. The management and outcome of anastomotic leaks in colorectal surgery. Colorectal Dis. 2008;10:587-592. (Pubitemid 351803065)